omniture
logo
Search
CRYSTALGENOMICS INC
Media Room

Latest News

rss

CG Pharmaceuticals Announces First Patient Dosed in Phase 1b/2 Study Evaluating Ivaltinostat for the Treatment of Pancreatic Adenocarcinoma

ORINDA, Calif. and SEOUL, South Korea, Aug. 18, 2022 /PRNewswire/ -- CG Pharmaceuticals, Inc. annou...

2022-08-18 21:00 1319

CrystalGenomics Appoints Gavin Choy, as President, CG Pharmaceuticals, Inc. to Lead Pipeline Expansion and Global Operations

SEOUL, South Korea, Oct. 7, 2020 /PRNewswire/ -- CrystalGenomics, Inc. (KOSDAQ: 083790), a commerci...

2020-10-08 08:35 1818